CompletedNot Applicable

CHILD (Child Health and Infection With Low Density) Malaria

Tanzania600 participantsStarted 2023-07-18

Plain-language summary

This trial will assess the long-term health and socioeconomic impact of interventions targeting low-density malaria infection (LMI) among children in Tanzania

Who can participate

Age range6 Months – 10 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. 6 months to 10 years of age of age at enrollment
✓. Primary residence in the study area during the study period
✓. Agree to come to study clinic for any illness
✓. Agree to avoid medications outside the study, even herbal medication

Exclusion criteria

✕. Another child from household already randomly selected for recruitment
✕. Not able or does not provide informed consent
✕. Need for emergency intervention
✕. Known history of chronic illness requiring regular specialty care including diabetes mellitus, cancer, or Stage 3 or 4 HIV/AIDS
✕. Contraindications to artemether-lumefantrine (AL) including history of allergic reaction, weight under 5 kg
✕. Participation in another active/ongoing intervention trial

What they're measuring

Incidence of all-cause sick visits

Timeframe: 24-30 months from enrollment

Trial details

NCT IDNCT05567016

SponsorUniversity of California, San Francisco

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-11-28

View on ClinicalTrials.gov More Malaria,Falciparum trials